IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES

[1]  S. Fuji,et al.  Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  A. Vekhoff,et al.  Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation , 2015, Bone Marrow Transplantation.

[3]  M. Kurokawa,et al.  Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia. , 2014, Blood.

[4]  W. Wiktor-Jedrzejczak,et al.  Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1–risk myelodysplastic syndrome and thrombocytopenia , 2014, Cancer.

[5]  E. Lanino,et al.  Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  U. Popat,et al.  Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. , 2013, American journal of blood research.

[7]  U. Gergis,et al.  Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation. , 2012, Journal of Clinical Oncology.

[8]  B. Chong,et al.  Romiplostim or standard of care in patients with immune thrombocytopenia. , 2010, The New England journal of medicine.

[9]  J. Tolar,et al.  Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim , 2010, Pediatric blood & cancer.

[10]  M. Kawahara,et al.  Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. , 2009, Blood.

[11]  J. Bussel,et al.  Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[12]  H. Heuft,et al.  Transfer of donor immune thrombocytopenic purpura to a recipient of an allogeneic haematopoietic stem cell graft , 2009, Bone Marrow Transplantation.

[13]  P. Cernelc,et al.  Splenectomy for Severe Autoimmune Cytopenias after Allogeneic Stem Cell Transplantation: Case Report , 2005, International journal of hematology.

[14]  C. Craddock,et al.  Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation , 2005, Bone Marrow Transplantation.

[15]  A. Jillella,et al.  Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options , 2000, Bone Marrow Transplantation.